Clinical Trials Directory

Trials / Completed

CompletedNCT05748756

Bone Marrow Aspirate Concentrate in Treating Mandibular Cystic Defects

The Effect of Bone Marrow Aspirate Concentrate in the Treatment of Mandibular Cystic Defects (Randomized Clinical Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Hams Hamed Abdelrahman · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Mandibular cystic defect healing is a complex process. Various methods have been developed to shorten the bone regeneration time and improve its quality. Autogenous grafting is the gold standard for filling cystic defects due to the osteogenesis property provided by the viable cells but is related to donor site morbidity. Allografts and Xenografts are used for the same purpose. However, the increased cost is their main disadvantage. Bone marrow aspirate concentrate is now used to enhance the healing and regeneration process in many areas of the body with no morbidity and low cost.

Conditions

Interventions

TypeNameDescription
OTHEREnucleation and filling by Bone marrow aspirateThe iliac crest is palpated along its widest part forming the iliac tubercle ( 5-6 cm posterior to the anterior superior iliac spine), then a 5 mm incision is made 3-4 cm posterior to the ASIS directly on the crest. The needle is advanced between the outer and inner plates of the ileum for a 4-6 cm into the cancellous bone and 10 ml of bone marrow is aspirated. Bone marrow aspirate is processed by a dual centrifugation technique.
OTHERConventional enucleation onlypatients were treated conventionally by enucleation and plain collagen sponge only.

Timeline

Start date
2022-01-19
Primary completion
2022-07-13
Completion
2022-07-17
First posted
2023-03-01
Last updated
2023-03-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05748756. Inclusion in this directory is not an endorsement.